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1. Introduction 
Bacteraemia and sepsis is associated with a high mortality and an increased incidence of 
hospital stay and associated costs (1, 2). A recent multicentre retrospective evaluation has 
shown that more than 80% of bacteraemias and fungaemias occur within the hospital or 
other heathcare settings, with indwelling catheters being the most common source (3). 
Blood cultures are still considered to be the ‘gold standard’ for the detection of microbial 
pathogens related to bacteraemia and sepsis despite newer molecular techniques (4, 5). This 
method allows for microbial identification and susceptibility testing to be performed which 
is a critical component to managing sepsis, however the lack of rapid results and decreased 
sensitivity for fastidious pathogens has led to the development of improved systems and 
adjunctive molecular or proteomic testing.  
Clinicians need to utilize their respective laboratories’ culturing systems optimally by 
adhering to the correct way of submitting blood culture specimens, understanding the 
principle of the testing method and making informed decisions regarding the results obtained.  
This chapter will focus on the use of blood culture systems in the era of modern technology 
and aim to highlight the best practice from collection to interpretation of results. 
2. The blood culture 
The term blood culture refers to a single venipuncture, either from a peripheral site or 
central or arterial line, with blood inoculated into one or more blood culture bottles. One 
bottle is considered a blood culture where two or more are considered a set. Multiple sets 
are from multiple venipunctures and are associated with different sites. 
Bacteraemia is defined as the presence of microorganisms in the blood, compared to sepsis 
which is defined as bacteraemia in the presence of clinical symptoms and signs such as 
fever, tachycardia, tachypnea and hypotension. 
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The sensitivity and specificity of the test are influenced by the clinicians’ ability to predict 
bacteraemia or sepsis prior to collection. The clinical indication will guide the timing and the 
numbers of cultures being send. The person taking the sample will also influence the results 
by adhering to aseptic technique and inoculating the correct volume. 
Blood cultures are taken to establish microbial invasion of the vascular system. Common 
mechanisms include dissemination from a primary site after inadequate control by host 
defense mechanisms, intravascular device mediated or infection of the vascular system e.g. 
infective endocarditis. Transient bacteraemia occur due to translocation of bacteria e.g. 
during chewing with rapid clearance by immune mechanisms compared to intermittent 
bacteraemia where bacteria are periodically released into the blood from e.g. an abscess 
while continuous bacteraemia points to an intravascular infection.  
Blood cultures should always be obtained to investigate the possibility of a bacteraemia. 
Various indications will lead to obtaining these samples (Table 1). Clinical parameters e.g. 
fever, raised inflammatory markers and suggestive imaging as well as a clinical suspicion of 
specific disease entities e.g. meningitis, pneumonia, osteomyelitis and pyelonephritis will 
prompt clinicians to investigate for bacteraemia. Part of the diagnostic criteria for infective 
endocarditis include obtaining positive blood cultures (6, 7). Blood cultures are taken to 
confirm or exclude central line associated bloodstream infection (CLABSI) as well as to 
follow up the response to therapy in certain conditions e.g. fungaemia and infective 
endocarditis. 
 
Acute bacterial sepsis Meningitis 
 Pneumonia 
 Osteomyelitis 
 Pyelonephritis 
Vascular Infective endocarditis 
Closed space infections Intra-abdominal abscesses 
Catheter related bacteraemia  
Follow up cultures Fungaemia, infective endocarditis 
Table 1. Indications for taking blood cultures 
The yield of blood cultures will depend on the site of infection. Up to 99% of blood cultures 
can be positive with acute suppurative thrombophlebitis, up to 50% with acute bacterial 
meningitis and only 2% with acute cellulites. 
3. Principles of blood culture collection 
Collection of blood cultures is a critical component and can either positively affect the 
patient outcome by providing an accurate diagnosis or adversely affect the outcome by 
prolonging antimicrobial therapy and the length of hospital stay with the isolation of a 
contaminant.  
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3.1. Timing 
In general, clinicians will collect blood cultures around the time of temperature elevation to 
increase the chance of detecting bacteraemia, however this practice can become complicated 
especially in patients that are hypothermic or unable to mount a temperature response with 
clinical sepsis. Fever can also be related to non-infectious causes e.g. drug reaction or 
malignancy. A multiceneter study showed no significant enhanced detection of bacteraemia 
when taking cultures around elevated temperatures (8). 
The general rule of sending two to three blood culture sets from different sites in a period of 
24 hours has also been challenged. For continuous bacteraemia e.g. infective endocarditis 
the first culture are likely to be positive in contrast to patients with intermittent bacteraemia 
where 3 or more cultures over a period of time may necessary to detect the pathogen. A 
study showed no difference in taking cultures simultaneously or serially at spaced intervals 
(9). 
Current recommendation with regard to timing and interval include obtaining two sets 
within minutes apart from two distinct sites at the onset of the 24 hour period with two 
subsequent sets being taking at different time intervals over the 24 hour period if the clinical 
condition deteriorates (10). 
Blood cultures taken while on antimicrobial therapy will prevent detection of some 
bacteraemias, therefore sampling should precede administration of antibiotics at all costs. If 
patients are on antimicrobial therapy, specific resin containing bottles must be used to 
neutralize antimicrobials and enhance pathogen detection. Antimicrobial therapy should 
however never be withheld to obtain subsequent cultures at different intervals. 
Key points! 
1. Blood cultures must be taken on suspicion of bacteraemia and not only around fever 
spikes. 
2. Two sets must be taken at the onset of a 24 hour period within minutes apart. 
3. Two more sets can be obtained during the 24 hour period if the clinical condition 
deteriorates. 
4. Blood cultures must be obtained before administration of antimicrobial agents. 
3.2. Site 
The recommended practice is to obtain a blood culture from a peripheral venipuncture, 
however patients who are critically ill and where venous access is a problem will have a 
central venous catheter (CVC) or an arterial line from which sampling can be performed. 
This practice has been discouraged due to the concerns of possible contamination (11, 12). 
Other studies have shown the benefit of using sampling from CVCs to detect bacteraemia 
(13, 14). A recent study by Beutz et al in 2003 evaluated the clinical utility of using blood 
cultures taken through central venous catheters and peripheral venipunctures in critically ill 
medical patients and found an overall good negative predictive value, however they 
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warned that in a setting with a high incidence of true bacteraemia the use of taking cultures 
either through CVCs or peripheral venipunctures should be interpreted with caution, as 
many critically ill patients who are receiving antimicrobials through their central lines can 
have negative cultures despite true bacteraemia. They recommend that in patients with a 
CVC, blood cultures from both the CVC and peripheral venipuncture should be obtained to 
increase sensitivity but that additional samples may be necessary to trouble shoot 
discordant results (15). A recent meta-analysis also showed better sensitivity and negative 
predictive value with cultures taken from an intravascular site and therefore recommends 
that at least one culture should be from the CVC (16).  
The practice of using the two needle technique, removing the needle after drawing the blood 
and attaching another sterile needle to inoculate the blood into the bottle, is currently 
discouraged due to the risk of acquiring needlestick injuries although a meta-analysis 
showed a slight reduction in contamination rates (17). 
Key points! 
1. Peripheral venipuncture is preferred. 
2. If an invasive line is present, do both and correlate. 
3. Keep in mind that the culture from the CVC may be negative if antimicrobials are 
administered through the line, despite true bacteraemia. 
4. Although the negative predictive value of one culture is good, the sensitivity of taking a 
culture either peripherally or through a CVC is not adequate. 
3.3. Skin antisepsis 
Blood culture contamination can lead to significant increase in healthcare related costs (12). 
Skin antisepsis therefore plays a critical role in reducing these contaminants.  
Various antisepsis agents are commercially available and these agents differ by onset of 
action, mechanism of action and cost. A comparison between povidine – iodine, 70% 
isopropyl – alcohol, tincture of iodine and povidine – iodine with 70% alcohol detected no 
significant difference with regard to blood culture contamination rates (18).  
Current infection control bundles for insertion of central line catheters and best practice 
guidelines for taking of blood cultures recommend using 2% chlorhexidine – gluconate in 
70% isopropyl – alcohol as skin antisepsis due to the enhanced activity compared to other 
formulations (19).  
In addition to alcohol containing antiseptics, the use of a prepackage antiseptic may play a 
role in reducing contamination rates (20). ChloraPrep (Enturia Limited) is a commercial 
antisepsis system that uses a plastic applicator to release 2% chlorhexidine – gluconate and 
70% isopropyl – alcohol into a sponge thereby reducing cross contamination from the care 
givers’ hands. A study by Tepus et al has shown a reduction in culture contamination rates 
(21) whereas another showed no significant decrease compared to 70% alcohol impregnated 
wipes (22).  
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Key points! 
1. Various skin antisepsis agents are commercially available. 
2. These agents are equally effective in reducing blood culture contamination rates. 
3. The current recommended agent for skin antisepsis when performing venipuncture is 
2% chlorhexidine – gluconate in 70% isopropyl – alcohol.  
3.4. Volume and number of cultures 
Adequate sample volume remains a critical factor to detect bacteraemia and have been 
evaluated extensively over last few years. Clinical and Laboratory Standards Institute (CLSI) 
recommend four 10 ml bottles to detect 90 – 95% of bacteraemias (23). In order to detect up 
to 99% of organisms a total of 60 ml of blood will need to be cultured (11).  
In the early 1980s Washington proposed that culturing of a higher volume will result in a 
higher detection rate of blood stream infections (24, 25, 26), however the question arose 
whether this dictum still holds true for the newer continuous monitoring blood culture 
systems. Weinstein answered the question by comparing the speed and yield of detection of 
microorganisms from aerobic bottles inoculated with both 5 ml and 10 ml using a 
continuous monitoring blood culture system by showing the overall recovery of 
microorganisms to be higher with the 10 ml inoculated bottles (P < 0.001) (27). 
An interesting study found that the higher the age of the patient and the severity of the 
underlying condition significantly influenced the collection and subsequent culturing of 
lower volumes of blood. The study also demonstrated that in critically ill patients, the 
higher the volume cultured, the more bacteraemias were detected and the yield of 
microorganism recovery increased by 3.5% per additional milliliter of blood cultured (28).  
Current recommendations include collecting at least two sets of, each 20 ml of blood 
distributed equally between an aerobic and an anaerobic bottle from two distinct sites (10, 
29). Lee et al reported that in order to detect 90% of true bacteraemias, 2 blood culture sets 
should be taken in a 24 hour period, however to detect > 99% up to 4 blood culture sets may 
be necessary (30). 
Single blood cultures should be discouraged due their lack of sensitivity and difficult 
interpretation e.g. isolating coagulase negative staphylococci (CoNS) from a single blood 
culture may represent contamination or true bacteraemia (29). 
A recent study reported yields from consecutive cultures from patients without infective 
endocarditis to be 65.1% after the first blood culture, 80.4% after the second blood culture 
and 95.7% after third blood culture. They also observed a high positivity from the first 
culture in patients with infective endocarditis which supports the observation of a 
continuous bacteraemia and fungaemia in this patient group (10). 
Although paediatric bottles have been adapted to accommodate much smaller volumes of 
blood the optimal amount remains unknown. It is common practice to culture not more than 
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1 – 2 ml of blood in neonates. One study suggests that failure to detect bacteraemia was 
more likely when culturing < 1 ml of blood (31). 
Human blood contains various factors or substances that can interfere with the detection of 
micro-organisms e.g. host serum factors and also antimicrobial agents. Therefore inoculated 
blood must be diluted to a point where these substances will have a minimal inhibitory 
effect. The required dilutional factor has been evaluated before and up to 10 times dilution 
has been recommended (32, 33), however the blood – broth ratio required for various 
systems will differ according to manufactures’ instruction. The VersaTREK (TREK 
Diagnostic Systems, Cleveland, Ohio) is adapted to accommodate smaller volumes from as 
little as 0.1 ml – 10 ml, however the manufacture still recommends using 10 ml to achieve a 
1:9 blood – broth ratio in the 80 ml bottle. Inoculating at dilutions higher than 1:10 may be 
associated with a lower yield due to the decreased overall volume cultured (29). 
Key points! 
1. The higher the volume, the higher the yield. 
2. Up to 4 blood culture sets in a 24 hour period may be necessary to detect > 99% of 
microorganisms. 
3. As least 1 ml must be cultured in neonates. 
4. Adequate blood – broth ratio of 1:10 must be achieved to dilute the effects of inhibitory 
substances and antimicrobials present in the blood. 
3.5. Training 
Education and training of staff responsible for collection of blood cultures is critical. Studies 
have shown a decrease in contamination rates associated with combining different measures 
with training (34, 35) with the one study reporting contamination rates from phlebotomist 
vs. non-phlebotomists to be 0.8% and 4.7% respectively (35). 
Key points! 
1. Lower contamination rates are possible with dedicated phlebotomists. 
3.6. Clinical information and labeling 
Although all positive blood cultures are regarded as significant, false positive results can 
occur and interpretation becomes critical. Clinical information can aid the laboratory to 
decide whether an isolate is more likely to be significant or a contaminant (See section on 
Blood culture contamination).  
Labeling of each bottle especially indicating the site through which the sample was taken is 
of critical importance to the laboratory. Sets taken through catheter lines are more likely to 
be contaminated and therefore correct labeling can aid interpretation. 
Avoid applying the label over the barcode or the bottom of the bottle, this practice cover the 
sensor that is critical for detection and can result in false positive signals. 
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Key points! 
1. Label bottle with the site where the sample was obtained from. 
2. Covering the sensor at the bottom of the bottle can result in false positive signals. 
3.7. Blood culture collection kits 
This new strategy to decrease blood culture contamination has been implemented in some 
centers. The kit contains a pre-packaged antiseptic e.g. ChloraPrep sponge, a blood 
collection set (needle, syringe, safety lock etc), bottles and an instruction leaflet. A study 
evaluating the impact of these blood culture collection kits showed a reduction in blood 
culture contamination rates from 9.2% – 3.8%, however introduction of the kit was 
associated with an unintended yet sustained decrease in the amount of blood cultures 
collected which may have resulted in an unwanted reduction in the amount of true Gram 
negative bacteraemias (34). The authors recommend using the kit with ongoing training and 
ensuring that availability and accessibility are not compromised. Weightman et al also 
reported a decrease in contamination rates observed at their centre after the introduction of 
blood culture collection kits from 6% - 2.7% without compromising the amount of 
investigations performed (35). 
Key points! 
1. Blood culture collection kits can decrease blood culture contamination rates. 
4. Selection of the correct blood culture bottle 
Blood culture sets generally consist of and aerobic an anaerobic bottle. Various different 
bottles are available depending on the continuous monitoring system used. These bottles are 
specifically designed to optimize recovery of both aerobic and anaerobic organisms. This 
section will highlight the principles of these bottles by discussing a few examples, more 
detail with regard to specific bottles not mentioned should be obtained from the 
manufacturer. 
Despite a decrease in the amount of anaerobic organisms isolated, the use of the anaerobic 
bottle as part of the routine blood culture set continuous. Various authors have questioned 
this practice (36, 37). Morris et al suggested that an approach of using two aerobic bottles 
with selective anaerobic culturing could enhance isolation with up to 6% (36), however this 
approach has not been adapted. Tamayose et al argued strongly to discontinue anaerobic 
culturing as routine practice and place attention on enhancing fungal isolation. (37). The 
anaerobic bottle however adds value in the fact that it allows growth of facultative 
organisms and thus adding to the total volume cultured and thus the sensitivity for 
organism recovery.  
Various culturing media within one system differ with regard to constituents and 
performance and the choice relies heavily on controlled clinical evaluation. The 
BacT/ALERT FN medium (bioMérieux, Durham, N.C.) recently replaced the BacT/Alert 
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anerobic FAN medium. They differ in composition with the amount of activated charcoal 
and broth constituents where the FN bottle contains a higher concentration of activated 
charcoal as well as trypticase soy broth compared to brain heart infusion. BacT/ALERT also 
has a standard anaerobic bottle SN which does not contain activated charcoal. Mirret el al 
compared all three anaerobic bottles with the standard aerobic bottle, the BacT/ALERT FA 
medium and found better recovery of micro-organisms and a faster time to positivity (TTP) 
with the FN bottle (38). 
Often the culturing media may differ in the structural format e.g. the BacT/ALERT 3D 
system (bioMérieux, Durham, N.C.) uses plastic bottles compared to the Bactec9240 system 
(BD Microbiology, Cockeysville,MD) that uses glass bottles. The VersaTREK system (Trek 
Diagnostic Systems, Cleveland, OH) offers media in two forms for both aerobic and 
anaerobic isolation, the 40 ml direct draw format which can accommodate 5 ml and an 80 ml 
format which can accommodate 10 ml. With the direct draw format the blood – broth ratio 
achieved is 1:8. Samuel et al compared the two media types with simulated blood cultures 
with clinically relevant microorganisms and found no negative impact on TTP with the 
smaller volume bottles (39). Caution should be applied in not compromising the total 
volume cultured when using small volume bottles as the recommended volume to be 
cultured still remains 30 ml of blood (See section on Principles of blood culture collection). 
Some blood culture bottles contain the anticoagulant sodium polyanetholsulphonate (SPS) 
that can inactivate some of the host serum factors but also have a toxic effect on some 
organisms. An overall balance is achieved with the correct blood – broth ratio. The blood – 
broth ratio required and achieved will be different between systems (See section on 
Principles of blood culture collection). Bottles also differ in terms of the antibiotic binding 
resins used to limit the effect of inhibitory substances. A study compared the Bactec Plus 
media and TREK Redox media and found the former to be more efficient in recovering 
organisms in the presence of antimicrobial substances (40). 
Paediatric bottles are specifically adapted to accommodate smaller volumes and often 
contain additional growth factors and binding resins to enhance organism recovery. A 
common misconception is that standard bottles cannot be used on paediatric patients and 
vice versa, however the choice of bottle will be dictated by the volume obtained. Although 
paediatric bottles are designed to maximize growth from smaller volumes the sensitivity to 
detect bacteraemia will increase with the volume of blood cultured. In neonates and infants 
it is assumed that you sample a much smaller pool and therefore the volume necessary to 
detect bacteraemia must be smaller, however as highlighted before the total volume 
required is not known and due to restriction in obtaining high volumes from this patient 
population this answer will keep eluding us. One study however has shown that the chance 
to fail to detect bacteraemia will increase when culturing < 1 ml in neonates (31). 
Some systems provide additional culturing media optimized to detect fungal or 
mycobacterial pathogens more efficiently, however these will not be addressed in this 
chapter. 
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5. From collection to incubation 
Over the years blood cultures has been regarded as one of the most import specimen types 
and microbiology laboratories take great care to process these as rapidly as possible. Blood 
cultures that have been collected must reach the laboratory as soon as possible and generally 
receive high attention for immediate incubation to allow optimal growth of organisms and 
rapid recovery without compromising the specimen. 
Although in principle, the bottles must be inserted within the continuous monitoring blood 
culture systems as soon as possible, various factors can affect the time to insertion (TTI). 
Some laboratories do not operate a full 24 hours and bottles will then be incubated at 35⁰C 
and can only be inserted the following day. Other factors include a delay in reaching the 
laboratory due to logistics. A study by Saito et al evaluated the effect of delayed insertion of 
blood culture bottles into continuously monitoring blood culture systems and found that 
although delayed insertion did not affect the sensitivity for organism recovery the mean 
TTP for all isolates was significantly shorter if inserted on the same day that the culture was 
obtained (41). 
Time to removal (TTR) is defined as the time elapsed from when the system emits a positive 
signal until the bottle is removed for subsequent subculturing for organism recovery. A 
delay in removal of the bottles could be due to closure of the laboratory at night and this can 
result in obtaining false negative results especially when isolating more fastidious 
organisms. In our study when evaluating the VersaTREK system against the Bactec9240 
system we found that the time to removal (TTR) for some isolates were up to 8 hours and 
this could have explained some false negative results where the system failed to detect S. 
pneumonia isolates (42). We know that this organism is prone to activate autolysin under 
stress conditions which may result in poor recovery from blood culture bottles. This 
phenomena has been observed with the BacT/ALERT 3D system in our laboratory where 
positive signals were obtained with subsequent no growth, however confirmed after 
positive agglutination from the bottle sediment (data not shown).  
The duration of incubation is calculated from the time of insertion until the time of removal. 
Bottles will be removed, thus considered negative, when no positive signal is obtained after a 
certain amount of incubation time has elapsed. This time before removal will depend on the 
blood culture system used. For manual broth – based systems, 7 days are the recommended 
incubation time (43) in comparison to various studies that support shorter incubation times of 
4 to 5 days with the continuous monitoring blood culture systems (44,45,46). 
Extended incubation (up to 14 to 21 days) is still recommended to detect more fastidious 
organisms specifically the HACEK organisms (Haemophilus, Actinobacillus, Cardiobacterium, 
Eikenella, and Kingella species) that are involved in endocarditis (7). Recent reports have 
shown that the method of detection and not the time of incubation is critical to detect these 
organisms. Baron et al in 2005 reported evidence that the Bactec9240 system can detect the 
HACEK organisms within 5 days (47). Alternative methods e.g. a lysis centrifugation system 
for dimorphic fungi and molecular methods for Bartonella henselae may be of more value 
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than prolonged incubation (47, 48). In a multicentre evaluation of 15 826 positive blood 
cultures only 0.1% of HACEK organisms were detected across all centers with a mean time 
to detection of 3.4 days. They recommend based on their findings that extended incubation 
for HACEK organisms is unnecessary (49). 
6. The choice of blood culture system 
Various commercial blood culture systems are available. The choice of blood culture system 
will depend on various factors (Table 2). It is the responsibility of the laboratory director to 
liaise with clinicians on the selection of the best system to achieve the best results for their 
specific patient population and workload.  
The various blood culture systems compete with regard to sensitivity for organism recovery, 
TTP, workload capacity, user interface and associated costs. Not one system is perfect and 
able to detect all possible micro-organisms. 
These systems all require inoculation of blood into a media bottle. The media are in 
principle similar, however controlled clinical trials have shown some media to be superior 
for certain organisms (See section Selection of the correct blood culture bottle).  
Sensitivity for organism recovery is the most import parameter when selecting a blood 
culture system. Studies have shown that the lysis centrifugation systems are more sensitive 
for the detection of fastidious organisms and dimorphic fungi (25). The continuous 
monitoring systems have shown superiority with regard to TTP compared to manual 
systems (50, 51, 52, 53) and are the current preferred systems. TTP has been shown to be a 
good predictor of clinical outcome in staphylococcal sepsis (54, 55, 56). 
 
Sensitivity for organism recovery 
Time to positivity 
Workload capacity 
User interface 
Costs 
Table 2. Factors that affect the choice of blood culture system 
The workload capacity is important as many laboratories differ in the amount of blood 
culture they will process. The continuous monitoring systems have the capacity to be 
expanded to accommodate the workload. The interface must be user friendly e.g. some 
technologists will review the growth index of the bottle to troubleshoot possible false 
positive signals. Cost of implementation and maintenance may play a role as well. 
6.1. Various commercial blood culture systems – Advantages and disadvantages 
There are currently a wide variety of blood culture systems available. Although the 
continuous monitoring blood culture systems have become the preferred platform, manual 
systems are still available and used in some settings and will be discussed briefly. 
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6.1.1. Manual blood culture systems 
The conventional manual method entails inoculating a commercially provided blood culture 
bottle, incubating the bottle at the required temperature and atmosphere with daily 
inspection of the bottle for macroscopic evidence of growth e.g. turbidity, haemolysis or 
colonies. Once growth is observed, a sample can be obtained for Gram staining and 
subculture for further identification. Bottles are incubated for 7 days and terminal 
subculture is mandatory. 
Variations to the conventional manual method is combining agar in the form of paddles to 
the broth. These systems allow for more frequent subculturing by inverting the bottles to 
bring the broth into contact with the agar. These bottles can be inspected for growth and 
Gram staining with presumptive identification to be performed from the agar.  
The Septi-Chek (BD Diagnostics) blood culture system is a biphasic-agar slide system that 
uses a standard blood culture bottle containing brain heart infusion or trypticase soy broth 
connected to a second plastic chamber with a trisurface panel consisting of chocolate, 
Mackonkey and malt agar. The slide chamber is screwed onto the bottle after inoculation 
and incubated at 35°C for 4 – 6 hours. The bottle is then inverted for the first subculture and 
can be inverted at various intervals thereafter to optimize isolation. 
The Oxoid Signal System (Oxoid Unipath, Basingstoke,England) is unique in the sense that 
it is a one bottle system. After inoculation of a standard blood culture bottle a second 
chamber is attached with a long needle that extends below the surface of the blood – broth 
mixture. This closed space system uses CO2 production to detect growth. Any gas produced 
will increase the pressure in the headspace and allow some of the blood – broth mixture to 
enter into the chamber from where sampling, Gram staining and subculturing can be 
performed. This system thus signals the laboratory towards possible growth without using 
an automated system. The advantages and disadvantages of these systems are presented in 
Table 3. 
 
Advantages Disadvantages
Evaluated favourably in detecting growth More false positives 
Cost effective Lower yield of anaerobes 
Useful in small laboratories with small 
workload 
Labour intensive, need to visibly inspect for 
growth 
Table 3. Advantages and disadvantages of manual blood culture systems 
6.1.2. Lysis centrifugation systems 
The principle of this test is explained in its name. The Wampole Isostat/ Isolater Microbial 
System (Inverness Medical) is a single tube test that uses saponin for lyses of erythrocytes 
and neutrophils, followed by centrifugation and subsequent inoculation of solid agar media 
for isolation. The system is useful for the recovery of slow growing and fastidious organisms 
including filamentous moulds, dimorphic fungi and Bartonella henselae (29). This method 
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also allows quantification to be performed, however limitations include a higher rate of 
contamination, excessive hands on time and toxic effects of the saponin that can inhibit 
growth. 
6.1.3. Continuous monitoring blood culture systems 
These systems are considered an advance in clinical microbiology and are the current 
preferred platform for blood culture testing worldwide. With the introduction of these 
systems in the 1970s they have evolved over time e.g. the Bactec series started with 
radiometric systems which was later replaced with non – radiometric systems. Today we 
face automated and computerized continuous monitoring blood culture systems. 
The three main commercially available systems are the BacT/ALERT blood culture system 
(bioMérieux, Durham, N.C), Bactec 9000 series (BD Microbiology, Cockeysville,MD) and 
the VersaTREK system (Trek Diagnostic Systems, Cleveland, Ohio). All three systems 
have expandable detection units with self-contained incubation chambers and minimal 
bottle manipulation as agitation is achieved via rocking or vortexing. The principle of 
detection of these systems is based on the release of CO2 in the presence of micro-
organism metabolism. 
The Bact/ALERT and Bactec systems both depend on a pH change due to the production of 
CO2 to detect growth. The Bactec9240 systems’ bottles have a sensor at the bottom that emits 
a fluorescent light as the CO2 concentration increases, that will pass via an emission filter to 
a light sensitive diode. The system measures the voltage every 10 minutes and compares the 
new value with the previous value and emits a positive signal as soon as the threshold value 
is reached. The BacT/ALERT 3D system uses a CO2 sensitive chemical sensor that is 
separated from the blood – broth mixture via a unidirectional membrane. Once the CO2 
concentration increases, the colour will change from green to yellow, this is measured with a 
photosensitive detector. 
The VersaTREK system monitors changes in the bottle headspace every 24 minutes. Both 
gas consumption and production are monitored. As a result other gasses e.g. O2 and H2 are 
also detected. The system differs from the other systems in that the aerobic bottles are 
vortexed with a magnetic stir bar to increase oxygenation. 
All three systems have been compared for both sensitivity for organism recovery and TTP. 
Mirret et al compared the VersaTREK system with the BacT/Alert system and found no 
significant difference for the detection of bacteraemia or fungaemia in clinical isolates (57). 
Our group compared the VersaTREK system against the Bactec9240 system and found both 
systems comparable to detect bacteraemia in patients with suspected sepsis however we 
observed a higher rate of false positive results and postulated that the threshold setting to 
emit a positive signal might be too low (42). Comparison of the BacT/ALERT system with 
the Bactec9240 systems showed slight better detection with the former (58). Advantages and 
disadvantages of these systems are shown in table 4. 
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Advantages Disadvantages
Higher sensitivity for organism recovery High implementation cost 
Faster TTP Equipment must be maintained 
Fully automated and computerized Need continuous power supply 
Easy loading and unloading of bottles  
Expandable to accommodate larger or 
smaller volumes 
 
Table 4. Advantages and disadvantages of continuous monitoring systems 
6.2. Time to positivity  
Time to positivity (TTP) is a parameter provided by the automated blood culture system 
and is calculated from the time of incubation until a positive signal is detected. TTP can be 
influenced by various factors e.g. the bacterial load, the growth rate of the micro-organism, 
the presence of antibacterial substances in the blood as well as source of infection and 
clinical features. 
Differential TTP has been used to diagnose CLABSI (59, 60, 61). Two sets of blood cultures 
are taken at the same time, one through the inserted catheter and the other peripherally. A 
CLABSI should be suspected if both sets yield the same micro-organisms and the set 
taken through the line becomes positive (TTP) 120 minutes or earlier than the peripheral 
set (62). 
Short TTP in S. aureus bacteraemia can possibly predict the source of infection, specifically 
an endovascular source and also correlate with the attributable mortality (54).  
Combining the TTP with the initial Gram stain result could predict the micro-organism as 
well as the source of bacteraemia, e.g. patients not on antimicrobial agents with Gram 
positive cocci in cluster within 14 hours was predictive of S. aureus, however the clinical 
impact of using this approach needs to be evaluated further (63). 
7. Interpretation of results 
Interpretation of positive blood culture results are challenging to both clinicians and 
microbiologists. With the background of blood culture contamination rates of up to half of 
all positive cultures and previously considered contaminants now more frequently 
implicated in disease the need for tools to assist in distinguishing contaminants from 
pathogens becomes eminent. 
Consensus have been reached with regard to clinical and laboratory parameters that must 
be taken into consideration to assess positive cultures for significance or contamination. 
These include fever, leucocytosis, positive imaging, the identity of the organism recovered, 
the number of sets positive out of the number received, the number of bottles positive 
within a given set and the TTP (64) (Table 5). 
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Clinical Laboratory
Fever Identity of the microorganism
Leucocytosis Number of positive sets
Positive imaging Number of positive bottles (within set) 
 Time to positivity
Table 5. Parameters as tools to distinguish contaminants from pathogens in positive blood cultures 
The identity of the microorganism can aid interpretation of results (11, 65). According to an 
evaluation by Weinstein et al in 1997 there are organisms that will be pathogens in > 90% of 
cases and these include Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, other 
Enterobacteriaceae, Pseudomonas aeruginosa and Candida albicans (66). Despite adequate data 
from large studies there are other organisms that also presents as true pathogens most of the 
time e.g. Streptococcus pyogenes, Streptococcus agalactiae, Listeria monocytogenes, Neisseria 
meningitidis, Neisseria gonorrhoeae, Haemophilus influenzae, Bacteroides fragilis group, Candida 
species other than C. albicans and Cryptococcus neoformans (64). Organisms that represent 
rarely as pathogens include Bacillus species, Propionibacterium acnes, Corynebacterium spp 
other than C. jeikieum and Viridans group streptococci (66, 67) (Table 6). 
 
True pathogen Probable contaminant
Staphylococcus aureus Coagulase negative staphylococci (CoNS)* 
Streptococcus pneumoniae Bacillis species
Escherichia coli Propionibacterium acnes
Other Enterobacteriaceae Corynebacterium spp
Pseudomonas aeruginosa  
Candida albicans  
*Contaminant or true pathogen 
Table 6. Organism identity to indicate significance or contamination 
Other organisms can no longer be judged on their identity with regard to significance, these 
include CoNS, Viridans group streptococci and Clostridium species. 
Isolating CoNS from positive blood culture bottles presents a challenge for clinicians in 
deciding the significance of the finding. Not only are CoNS the most common contaminant 
isolated but patients who presents with true infection often have mild symptoms which 
makes the interpretation very difficult (68,69). Various studies are reporting CoNS to be a 
true pathogen causing blood stream infections especially in patients with indwelling 
prosthetic devices or central venous catheters (66, 70). 
The value of obtaining more than one set of blood cultures not only enhances the yield of 
detecting bacteraemia, but also aids interpretation when dealing with positive cultures. 
Contaminants are often obtained from only one set whereas with true bacteraemias multiple 
blood cultures will grow the same organism (66). Weinstein also reported that if an 
institution has a baseline contamination rate of about 3%, the chances of recovering the same 
organism in a two set culture and being a contaminant is less than 1 in a 1000 (64). 
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Using the TTP as an aid to establish significance have been debated before (64). The 
principle relies on the assumption that true infection will present with a much larger 
inoculum vs. contamination and thus result in earlier detection. One of the reasons why TTP 
can be misleading is the fact that continuous monitoring systems can detect micro-
organisms at lower levels much faster than conventional systems. 
Using the criteria that if one bottle is positive within a given set relates to contamination 
should be discouraged. For CoNS this has been evaluated and shown to be inadequate to 
predict clinical outcome (71). 
8. Blood culture contamination 
Culture contamination represents false positive results and are not uncommon in microbiology 
laboratories with rates being reported as high as around 50% of all positive cultures (66, 72). An 
increase in contamination rates despite advances in the field of microbiology has been observed 
(66) and this phenomenon could be explained by the increasing use of continuously monitoring 
blood culture systems and the improved culture media provided for the specific systems that 
may aid the detection of low numbers contaminants. The increased use of intravascular devices 
and the practice of taking cultures through invasive lines are also important when considering 
contamination rates. American Society of Microbiologists published standards that state that 
blood culture contamination rates must not exceed 3% (73), rates however will differ widely 
between institutions, but commonly exceeds 7% (74, 75).  
The cost of blood culture contamination often exceeds the cost of performing the test (76). A 
retrospective case-control study evaluated 142 false positive blood cultures and found a 
significant increase in length of hospital stay as well as laboratory and pharmacy costs, they 
also calculated that the 254 false positives blood cultures in a year period, added 1372 extra 
hospital days and £1,270,381 in costs per year (77). 
Various strategies have been implemented to decrease blood culture contamination rates 
e.g. training staff with regard to aseptic collection technique, feedback with regard to 
contamination rates and implementation of blood culture collection kits. Although skin 
antisepsis can reduce the burden of contamination, 20% of skin organisms are located deep 
within the dermis and are unaffected by antisepsis (78). The practice of changing needles 
before bottle inoculation should be abandoned as it increases the risk to acquire needle stick 
injuries without decreasing contamination rates (79). Also discarding the initial aliquot of 
blood taken from CVCs does not reduce contamination (80). 
9. New technologies used in conjunction with blood culture systems in 
the diagnosis of sepsis 
In hospital settings where resistance profiles of circulating micro-organisms are known, 
the use of rapid identifying methods to guide empiric antimicrobial usage is critical to 
improve patient outcomes. Research efforts are focused on developing molecular tests 
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that can be performed without prior culturing with continuous monitoring systems, 
however these assays are limited to date. Molecular assays performed on positive blood 
culture bottles has improved sensitivity compared to conventional culturing methods, and 
has decreased turnaround times compared to routine culture (81). Study by Karahan have 
shown the use of molecular methods to evaluate false positive signals for identifying 
microbial DNA of organisms that might have been inhibited by high leucocytes count or 
antimicrobials (82). 
The Lightcycler® SeptiFast (Roche Diagnostics, Manheim, Germany) is a multiplex realtime 
PCR system that can detect up to 25 common pathogens involved in sepsis from one single 
blood sample within 6 hours. Various studies have evaluated the use and confirm increased 
detection of circulating microbial DNA compared with conventional blood culture (83, 
84,85). Study by Lucignano et al evaluated the use in the paediatric population with 
suspected sepsis with sensitivity and specificity reported of 85% and 95% respectively. 
Significantly higher yields were observed from patients already on antimicrobial therapy 
(86). Although this method is considered culture – independent, most studies agree that this 
system does not replace conventional blood culturing and the clinical significance of 
detecting higher amounts of microbial DNA must be further evaluated. 
A new strategy for the detection of blood stream pathogens include PCR/Electrospray 
ionization and mass spectrometry (PCR/ESI-MS). This technique in short amplifies broadly 
conserved regions of bacterial and fungal genomes followed by mass spectrometric analysis 
by weighing the PCR amplicons and comparing the product with known standards. The 
commercial assay is the Bac Spectrum Assay that runs on the PLEX-ID (Abbott Molecular). 
A study by Eshoo et al showed good sensitivity and specificity for the detection of Erlichia 
species in the blood from patients with suspected erlichiosis with the identification of 
additional bacterial pathogens that was determined to be clinically relevant (89). This new 
method will likely change the future of diagnosis of bloodstream pathogens however 
clinical relevant studies needs to be performed. 
The Prove-it sepsis assay (Mobidiag, Helsinki, Finland) is a DNA-based microarray platform 
can identify more than 50 Gram positive and Gram negative bacteria that can cause sepsis 
(87) as well as detect the presence of the mecA gene that codes for methicillin resistance in S. 
aureus (88) from positive blood culture bottles. Sensitivity and specificity compared to 
conventional culture are reported to be 94.7% and 98.8% respectively (81). The study also 
showed an 18 hour faster turnaround time for identification compared to conventional 
culture. Due to the multiplexing capabilities this assay can also be expanded to detect 
pathogens involved in fungaemia. 
The Xpert MRSA/SA Blood culture assay (Cepheid) was evaluated favourably for the 
detection of an the discrimination between methicillin resistant staphylococcus aureus (MRSA) 
and methicillin susceptible staphylococcus aureus (MSSA) (90) . Although this method is 
limited with regard to the range of pathogens it will guide initial empiric therapy towards a 
better clinical outcome. 
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Another new approach to enhance earlier specie identification from positive blood culture 
bottles following Gram staining include the Peptide Nucleic Acid Fluorescence In situ 
Hybridization assay (PNA-FISH). This assay uses probes that target specific conserved 
bacterial and fungal genomic regions and can distinguish between e.g. S. aureus and non – S. 
aureus as well as different Candida species (91, 92, 93). 
Matrix-assisted Laser Desorption/Ionization–time of flight (MALDI-TOF) mass 
spectrometry (MS) is currently widely applied on post culture isolates for rapid 
identification. The system use MS signals created and compare them to standard signal 
patterns within a database. The use directly from positive blood culture bottles needs 
further evaluation but the advantage of this technology shows promise for the future. 
The various new technologies appears attractive, however implementation will come at 
great cost and are not cost effective for routine laboratories at present. Certainly the rapidly 
of results being generated and the ability to detect pathogens unlikely to grew on 
conventional media comes as a great advantage. The clinical significance of enhanced 
detection of circulating microbial DNA must be established.  
10. Conclusion 
The use of blood culture systems still remain the gold standard for the detection of 
bacteraemia. It is important to understand the process from collection to obtaining a result 
to aid interpretation and improve the clinical outcome. While the continuous monitoring 
systems are the preferred platform for testing, various new methods are on the horizon that 
will aid or even replace these systems, only time will tell. 
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